Skip to content

Biogen BIIB EV / EBITDA

EV / EBITDA at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
16.4×-5.2×
Eli Lilly logo
Eli LillyLLY
25.9×-24.4×
Royalty Pharma logo
Royalty PharmaRPRX
13.9×+1.7×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
12×+0.4×
Amgen logo
AmgenAMGN
15.9×-1.3×
Incyte logo
IncyteINCY
-28.2×

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Net income$319.5M+32.9%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$29.33B+34.3%
Enterprise value$32.51B+34.9%
P/E20.6×+5.9×
P/S+0.7×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Calculated from Biogen’s reported figures.

Based on the most recent quarter.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's EV / EBITDA?
Biogen (BIIB) reported EV / EBITDA of 11.2× in Q1 2026.
How has Biogen's EV / EBITDA changed year-over-year?
Biogen's EV / EBITDA increased by 32.6% year-over-year, from 8.4× to 11.2×.
What is the long-term trend for Biogen's EV / EBITDA?
Over 4 years (2021 to 2025), Biogen's EV / EBITDA has grown at a -11.6% compound annual growth rate (CAGR), from 59× to 36.1×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.